Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis

European Journal of Neurology

Volumn 16, Issue 12, 2009, Pages 1318-1322

  Yeh, J H ^a,b   Wang, S H ^c   Chien, P J ^c   Shih, C M ^d   Chiu, H C ^a,b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cytokines; Myasthenia gravis; Plasmapheresis

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CYTOKINE; GAMMA INTERFERON; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE FILTRATION PLASMAPHERESIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPATHOGENESIS; LOADING DRUG DOSE; MALE; MEDICAL INSTRUMENTATION; MONITOR; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; PLASMA VOLUME; PLASMAPHERESIS; PRIORITY JOURNAL; SERUM; THYMECTOMY;

ADOLESCENT; ADULT; AGED; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PLASMAPHERESIS; YOUNG ADULT;

EID: 70450159804     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02729.x     Document Type: Article

References (19)

1. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009 8 : 475 490.
2. Aarli JA. Role of cytokines in neurological disorders. Curr Med Chem 2003 10 : 1931 1937.
3. Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV. Serum interleukin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 1991 30 : 48 53.
4. Bongioanni P, Ricciardi R, Romano MR. T-lymphocyte interferon-gamma receptor binding in patients with myasthenia gravis. Arch Neurol 1999 56 : 933 938.
5. Jander S, Stoll G. Increased serum levels of the interferon-gamma- inducing cytokine interleukin-18 in myasthenia gravis. Neurology 2002 59 : 287 289.
6. Confalonieri P, Antozzi C, Cornelio F, Simoncini O, Mantegazza R. Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serum. J Neuroimmunol 1993 48 : 33 36.
7. Tesar V, Jelinkova E, Jirsa M Jr., Bakosova M, Pitha P, Chabova V. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange. Blood Purif 2000 18 : 115 120.
8. Bongioanni P, Ricciardi R, Romano MR, Murri L, Muratorio A. T-cell interleukin-6 receptor binding in patients with myasthenia gravis. J Neurol Sci 1998 158 : 215 220.
9. Yi Q, Ahlberg R, Pirskanen R, Lefvert AK. Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J Neuroimmunol 1994 50 : 177 186. (Pubitemid 24071783)
10. Link J, Navikas V, Yu M, Fredrikson S, Osterman PO, Link H. Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis. J Neuroimmunol 1994 51 : 185 192.
11. Huang YM, Kivisäkk P, Ozenci V, Pirskanen R, Link H. Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG). Clin Exp Immunol 1999 118 : 304 308.
12. Zhang GX, Navikas V, Link H. Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve 1997 20 : 543 551.
13. Utsugisawa K, Nagane Y, Obara D, Kondoh R, Yonezawa H, Tohgi H. Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis. Eur Neurol 2003 49 : 160 163. (Pubitemid 36359465)
14. Yeh JH, Chen WH, Hwang KM, Chiu HC. Prethymectomy plasmapheresis in myasthenia gravis. J Clin Apheresis 2005 20 : 217 221.
15. Yeh JH, Chien PJ, Hsueh YM, Shih CM, Chiu HC. Changes in lymphocyte subset after double-filtration plasmapheresis. Am J Clin Pathol 2007 128 : 940 944.
16. Stegmayr BG. Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996 14 : 94 101.
17. Goto H, Matsuo H, Nakane S, et al. Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes. Ther Apher Dial 2001 5 : 494 496.
18. Matusevicius D, Navikas V, Palasik W, et al. Tumor necrosis factor-α, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis. J Neuroimmunol 1996 71 : 191 198.
19. Kambara C, Matsuo H, Fukudome T, Goto H, Shibuya N. Miller Fisher syndrome and plasmapheresis. Ther Apher Dial 2002 6 : 450 453.